Correvio Pharma Corp. Finite-Lived Intangible Assets, Gross
Correvio Pharma Corp. had Finite-Lived Intangible Assets, Gross of $34.15 million as of 2016-12-31, per its 40-F filed 2017-03-29.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2017-03-29
- 2016-12-31: Finite-Lived Intangible Assets, Gross $34.15M.
- 2015-12-31: Finite-Lived Intangible Assets, Gross $21.27M.
- 2014-12-31: Finite-Lived Intangible Assets, Gross $21.23M.
- 2013-12-31: Finite-Lived Intangible Assets, Gross $21.14M.
| Period end | Finite-Lived Intangible Assets, Gross |
|---|---|
| 2016-12-31 | $34.15M 40-F · filed 2017-03-29 |
| 2015-12-31 | $21.27M 40-F · filed 2017-03-29 |
| 2014-12-31 | $21.23M 40-F · filed 2016-03-29 |
| 2013-12-31 | $21.14M 40-F · filed 2015-03-27 |